Sigrid Therapeutics (Sigrid) is excited to announce that it has secured U.S. market access for its proprietary SiPore® technology, following the success of the SHINE study, the largest of its kind in prediabetes. The study demonstrated that Carb Fence™, a medical-grade, fast-acting liquid formula powered by SiPore®, effectively reduces long-term blood sugar levels HbA1c (A1C), improves glucose metabolism, and reduces body weight - while preserving muscle mass.

Follows successful e-commerce launch for innovative blood sugar management solution

Over 91% of U.S. and Swedish customers surveyed report that the 100% natural GLP-1 companion product provides more stable glucose levels, reduces bloating, and curbs the urge to snack

Sigrid Therapeutics announces that it has been granted a US patent for its SiPore® platform technology.

Sigrid Therapeutics announces the completion of the final patient visit in its SHINE clinical trial—the largest of its kind—surpassing the planned enrollment of 288 with a total of 318 participants.

Sigrid Therapeutics announces strategic partnership with GetHealthy.store for healthcare and nutritional products.

Sigrid Therapeutics announces the completion of enrollment for the SHINE clinical trial.

SiPore® SMART silica particles provide formidable first line defense against caries and plaque formation

SHINE is the largest ongoing clinical study of its kind, marking a milestone in research on prediabetes and weight control. It involves individuals who are living with excess weight or obesity and have prediabetes or type 2 diabetes.

Sigrid Therapeutics, a clinical-stage healthtech company dedicated to revolutionizing the management of obesity and diabetes prevention with a novel, fast-acting, non-pharmaceutical technology, announced today it entered into an agreement with Cencora (formerly AmerisourceBergen) aimed at accelerating the commercialization of its SiPore® technology.

The Natural Silica-Based Supplement Effective at Controlling Blood Sugar and Weight Will be Sold Exclusively In-Store at Pure Pharmacy Starting Jan. 2, 2024.

Designed to Control Blood Sugar and Weight Without Prescriptions, The Glucose Stabiliser is a Natural Silica-Based Solution.

Both Nordic and international investors were attracted by Sigrid’s natural, non-drug alternative SiPore® technology

SiPore21® Silica "Molecular Sieves" Offer a Promising Non-Pharmaceutical Alternative

World-renowned oral healthcare expert joins Sigrid’s SAB to investigate impact of the SiPore® technology on both the oral microbiome and systemic inflammatory conditions

Sigrid Therapeutics unveils SiPore® to prevent oral pathogenic bacterial growth and plaque formation at International Dental Show 2023

“Molecular sieves” swallowed in capsules and gels reported safe, easy to digest and effective

Results back use of MSPs for novel diabetes and obesity treatments

Swedish Health and Wellbeing company on track for 2023 consumer supplement launch and entry into the veterinary market

Company aims to capitalize on new health and wellbeing market opportunities for SiPore® supplements